5,101 shares flagged for resale at LifeStance (NASDAQ: LFST) in Form 144 filing
Rhea-AI Filing Summary
LifeStance Health Group reported a Form 144 notice disclosing the intended sale of 5,101 shares of Common Stock. The filing lists a reported sale on 04/21/2026 of 5,101 shares with proceeds shown as $35,749.48. The filing also records prior private‑placement transfers of 3,876 shares on 06/01/2017 for two trust-to-LLC transfers (Vitthal and Shama).
Positive
- None.
Negative
- None.
Insights
Form 144 discloses an insider resale notice for 5,101 shares reported April 21, 2026.
The filing shows a reported disposition of 5,101 shares with proceeds of $35,749.48. This is a regulatory notice required when affiliates plan to sell restricted or control securities; it does not by itself confirm executed market transactions.
Timing and execution details beyond the reported sale date are not provided in the excerpt; subsequent trading activity and Rule 144 qualification status would appear in later transaction reports.
The submission lists historical private placement transfers of two 3,876-share lots from gift trusts to LLCs (06/01/2017).
Those entries indicate transfer history for specific lots acquired in a private placement and later moved from named trusts to affiliated LLCs. The notice treats these holdings as the source for the resale filing.
Cash‑flow treatment and whether sales were subject to Rule 144 holding periods or volume limits are not stated in the excerpt.